Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : ccam -- Ignore unavailable to you. Want to Upgrade?

To: Alfred W. Post who wrote (31)	11/16/2001 11:51:41 AM
From: Crossy	Read Replies (2) \| Respond to of 85

Frd, Dr. Reddy is an interesting stock to be sure, I just fear I'm a tad late to the party. Price/Sales is around 3.5 now. In the generics pharma business that is average. Below average in PSR are just BPRX, HITK and ALO. A double is defitely possible but I honestly do think there are even more attractive pharma companies out there (AMRN, HITK, BPRX) that could yield even more potential. My style is to find ground floor opportunities before they take off. That's a tough way to describe RDY <g>. Anyway good luck with your investment you really must like RDY especially after its rocket like surge.. rgrds CROSSY